\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Studies on Majoon Aarad Khurma and its Granules Prepared with Stevia, with Reference to the Standardization and Toxicity Evaluation},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2018-01-15 (revised: 15 January 2018)}
\def\TheID{\makeatother }
\def\TheDate{2018-01-15}
\title{Studies on Majoon Aarad Khurma and its Granules Prepared with Stevia, with Reference to the Standardization and Toxicity Evaluation}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Mateen Ahmad  Khan}

\renewcommand\Authands{ and }

\date{\small \em Received: 9 December 2017 Accepted: 1 January 2018 Published: 15 January 2018}

\maketitle


\begin{abstract}
        


There is a huge treasure of Compound drugs described in various pharmacopoeias that have developed as a result of painstaking and cumulative efforts of elite scholars of Unani medicine. However, there has always been scope for inclusion of new compound drugs whose safety and efficacy has been proved scientifically.Majoon Aarad Khurma which is widely used as an effective aphrodisiac is prepared with sugar as base. It is contraindicated in diabetic patients who are suffering from sexual dysfunctions. Preparation of medicines which are sugar free should be innovated or designed to meet the demand of the diabetic patients. Therefore the present study is aimed to develop granules of Majoon Aarad Khurma with natural sweetening agent Stevia rebaudiana. Granules are more convenient and comfortable in usage and dispensing. Granules uphold the same principles and maintain the same characteristics as traditional dosage forms, granules are safe, light, efficacious, stable and quality controlled.

\end{abstract}


\keywords{aphrodisiac, pharmacopoeias, diabetes, sexual dysfunction, granules, stevia rebaudiana, ccrum, sweetening agent.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 \par
Studies on Majoon Aarad Khurma and its Granules Prepared with Stevia, with Reference to the Standardization and Toxicity Evaluation Mateen Ahmad Khan ? , Yasmeen Ansari ? , Roohi Zaman ? \& Izharul Hasan ? Abstract-There is a huge treasure of Compound drugs described in various pharmacopoeias that have developed as a result of painstaking and cumulative efforts of elite scholars of Unani medicine. However, there has always been scope for inclusion of new compound drugs whose safety and efficacy has been proved scientifically.\par
Majoon Aarad Khurma which is widely used as an effective aphrodisiac is prepared with sugar as base. It is contraindicated in diabetic patients who are suffering from sexual dysfunctions. Preparation of medicines which are sugar free should be innovated or designed to meet the demand of the diabetic patients. Therefore the present study is aimed to develop granules of Majoon Aarad Khurma with natural sweetening agent Stevia rebaudiana. Granules are more convenient and comfortable in usage and dispensing. Granules uphold the same principles and maintain the same characteristics as traditional dosage forms, granules are safe, light, efficacious, stable and quality controlled.\par
In present study an important Unani formulation i.e. Majoon Aarad Khurma has been modified into granules using Introduction ccording to the Unani system of medicine, the health is a state of body in which there is equilibrium in humors and functions of the body. To maintain the correct humoral balance there is a power of self preservation called "Quwwate Mudabbirahe Badan" (Immunity of body) in the body.\par
Therefore the aim of the Unani physician is to find out the cause of the underlying disruption of humors, so that it can be corrected and disease can be cured. The temperament of the person is identified and diet/medicine/other recommendations are made that are most suitable for achieving and maintaining health of the particular person.\par
Sexual function is an important component of quality of life and subjective well being of humans. Human sexuality is a multidimensional phenomenon having biological, psychological, behavioral, clinical, moral and cultural aspects. It has been integral part of all cultures since time immemorial. But no single dimension of sexuality is universally dominant. Every person has sexual feelings, attitude and believes, but everyone's experience is unique because it proceeds through an intentionally personal prospective. The cardinal phases in sexual act in male are desire, erection, penetration and orgasm. The phases of sexual act in females are quite different from male. Usually in medicine and also in cultural aspects, sexuality has been mainly concerned with male sexual desire which increase in proportion to the level of secretion of the sex hormones. Sexual response is triggered by both psychological and physical stimuli. Sexual problems are widespread and adversely effects mood, well being, and inter-personal functioning.\par
Unani medicine treats sexual debility in its own way and proposes different methods of treatment Ilaj bil Ghiza (Ditotherapy), Ilaj bil Dawa (Pharmacotherapy) and Ilaj bit Tadbeer (Regimental therapy). Therapeutic use of the drugs is based on certain principles. The sexual problems are taken up in individualized way taking into account the entire personality of the patient \hyperref[b0]{1} . Unani medicine has holistic approach towards diagnosis and treatment of sexual dysfunction that is not just confined to inability to perform the sex rather includes loss of libido, erectile dysfunction, ejaculatory insufficiency, an orgasmic state, excessive nocturnal emissions and even infertility in males, which may be due to Zoofe Bah (sexual dysfunction) or Nuqse Mani (seminal defects). It also distinguishes between sexual inadequacy and seminal inadequacy \hyperref[b1]{[2]}\hyperref[b2]{[3]}\hyperref[b3]{[4]} .\par
In present study an important Unani compound formulation Majoon Aarad Khurma has been modified into granular form using natural sweetening agent Stevia rebaudiana which has sweetening property as well as hypoglycemic activity, the granules of Majoon Aarad Khurma become palatable and will not cause any harm to diabetic patients who are suffering from sexual dysfunction. This study also includes evaluation of physicochemical standards of Majoon Aarad Khurma and granules of Majoon Aarad Khurma and their safety and toxicity study. 
\section[{II.}]{II.} 
\section[{Material and Methods}]{Material and Methods}\par
According to the protocol of the study "Studies on Majoon Aarad Khurma and its Granules prepared with Stevia, with reference to the Standardization and Toxicity Evaluation" Majoon Aarad Khurma and Granules of Majoon Aarad Khurma was prepared in the laboratory of Dept. of Ilmul Saidla, NIUM. 
\section[{III.}]{III.} 
\section[{Preparation of Majoon Aarad Khurma}]{Preparation of Majoon Aarad Khurma}\par
All the required ingredients of Majoon Aarad Khurma and Granules of Majoone Aarad Khurma were procured from the raw drug dealers under the supervision of the Guide, and all the raw drugs were identified and authenticated by the expert Dept. of Ilmul Advia, NIUM Bangalore, (Karnataka).\par
The Majoon Aarad Khurma was prepared as per the formulation mentioned in the National Formulary of Unani Medicine, Part-1, Govt. of India. The composition of Majoone Aarad Khurma is as given below: The dried raw drugs from 2-7 mentioned in table were powdered in mixer and sieved in (sieve number 80), raw drugs from 8-11 were powdered separately and sieved in (sieve number 40), and dates were separately dried in a hot air oven at 100°C for 4 hours then powdered and passed through (sieve number 60). Qiwam was prepared according to method mentioned in Formulary with 1 kilo sugar and 600 ml water; the dried drugs were mixed one by one in the Qiwam and stirred slowly. Finally all the Maghaziyat (Kernels) 8-11 were mixed gradually in the Qiwam. And stored in a container at room temperature for further study \hyperref[b4]{5} . 
\section[{IV. Preparation of Granules of Majoon Aarad Khurma}]{IV. Preparation of Granules of Majoon Aarad Khurma}\par
The granule of Majoon Aarad Khurma was prepared as per the formulation mentioned in the National Formulary of Unani Medicine, Part-1, Govt. of India, the composition of granules of Majoon Aarad Khurma is as given below: All the dried ingredients were powdered and sieved in (sieve number 80). All the Maghaziyat (kernels) were powdered separately and sieved in (sieve number 40), and dates were separately dried in a hot air oven at 100 °C for 4 hours and then powdered and passed through sieve number 60. Stevia plant extract was prepared with 120 ml water at low temperature for 15 minutes, and sieved through muslin cloth, the total quantity of this extract obtained was 80 ml. All the dried drugs were mixed one by one in Stevia extract, and subjected into the granulator (sieve number 20) for formation of granules and then stored in container at room temperature for further study \hyperref[b4]{5} .\par
V. 
\section[{Acute Toxicity Study a) Experimental Animal}]{Acute Toxicity Study a) Experimental Animal}\par
Swiss mice of both sexes, weighing 25-35 gm were used. The animals were procured from the, Sri Raghvendra Enterprises, Vijayanagar, Bangalore, Karnataka (India).\par
Prior to the experiment the animals were allowed to acclimatized for at least one week. They were maintained under standard laboratory conditions throughout the experimental period and were provided with standard diet and water ad libitum unless stated otherwise. They were housed in clean polypropylene cages at room temperature 25±2°C, humidity at 45-55\% with 12 hours light: 12 hours dark cycle. The animal care procedures and experimental protocol were in according with the guidelines of CPCSEA. 
\section[{b) Extractive Values 6}]{b) Extractive Values 6}\par
For the determination of extractive values in non-successive of GMAK was carried out in Soxhlet apparatus, with hydro-alcoholic solvents i.e. 50\% distilled water and 50\% ethanol (1:1) ratio.  {\ref 7, 8 -15} Acute toxicity test was performed according to the World Health Organization (WHO) guideline (WHO  2000) and the Organization of Economic Co-operation and Development (OECD) guideline for testing of chemicals 420 (OECD 2001). Swiss mice of either sex weighing 25-35 gram were randomly assigned to four groups (I, II, III, \& IV,) of 7 mice each. Mice were fasted overnight (12 hrs) with free access to water prior to administration of single doses (0.398, 5.73, 9.73, \& 16.69 g/kg b.wt.). The extract dissolved in distilled water and administered orally once a day. After the administration of the test drug all the animals were kept in polypropylene cages singly and were observed for Gross behaviour and mortality at 0 min, 30 min, 60 min, 120 min, 240 min and 24 hrs. The Gross behavioural changes such as piloerection, grooming, trembling, wriggling, diarrhoea, breathing difficulty, constant changing position, immobility, asthenia, anorexia, ataxia, urination and syncope were monitored continuously for any above abnormal changes. 
\section[{c) Methodology for Acute Toxicity Study}]{c) Methodology for Acute Toxicity Study} 
\section[{VI.}]{VI.} 
\section[{Physico-Chemical Evaluation}]{Physico-Chemical Evaluation}\par
The Physico-Chemical studies were carried out on Majoon Aarad Khurma and Granules of Majoon Aarad Khurma in the laboratory of Dept of Ilmul Saidla, NIUM, Bangalore. Majoon Aarad Khurma and Granules of Majoon Aarad Khurma were prepared and subjected to Physico-Chemical evaluation under the following parameters:\par
(1) Organoleptic properties such as the appearance, colour, smell, and taste (2) Alcohol soluble matter and Water soluble matter (3) Successive extractive values (4) PH value (5) Bulk density and Tapped density (6) Ash value (7) Volatile oil (8) Saponification value (9) Iodine value (10) Acid value (11)  Estimation of total Alkaloids (12) Resin (  {\ref 13}) Reducing and non-Reducing sugars (14) Crude fibers (15) Thin layer chromatography (TLC) was also conducted for identification of compounds. 
\section[{VII.}]{VII.} 
\section[{Results and Observation}]{Results and Observation}\par
Both the test drugs sample Majoon Aarad Khurma and granules of Majoon Aarad Khurma were evaluated for physico-chemical parameters as recommended and almost all the values of both the test drugs were found within the standard limits.  
\section[{Chemical Evaluation}]{Chemical Evaluation}\par
a) Thin Layer Chromatography: \hyperref[b15]{[16]}\hyperref[b16]{[17]}\hyperref[b17]{[18]}\hyperref[b18]{[19]}\hyperref[b19]{[20]}\hyperref[b20]{[21]} {\ref [22]}\hyperref[b21]{[23]}\hyperref[b22]{[24]}\hyperref[b23]{[25]}\hyperref[b24]{[26]}\hyperref[b25]{[27]} {\ref [28]}\hyperref[b26]{[29]} Thin layer chromatography was carried out on T.L.C. pre coated aluminium plates, silica gel 60 F 254 (layer thickness 0.25 mm) for ethanolic extract of both the test drug samples MAK and GMAK in various mobile phases, later sprayed by different spraying reagents to visualise the spots. The R F values of the spots were calculated for both the drugs by the following formula.   The acute toxicity study was done on Swiss mice of either sex using Hydro-Alcoholic extract of granules of Majoon Aarad Khurma orally, no behavioural changes and mortality was found during 24 hours observation period. 
\section[{IX.}]{IX.} 
\section[{Discussion}]{Discussion}\par
Majoon Aarad Khurma is one such popular drug which is widely used as an effective aphrodisiac, which is prepared with sugar as base but as we know that the intake of sugar is not advisable in diabetic patients because the presence of sugar in large amount in blood may develop the complications of diabetes more rapidly so any preparation having sugar as a base or content may create such risk. So even after gaining such popularity as an aphrodisiac, Majoon Aarad Khurma cannot be given to diabetic patients who are suffering from erectile dysfunction. Hence sugar free an alternate formulation should be innovated or designed to meet the demand of the diabetic patients. 
\section[{X.}]{X.} 
\section[{Conclusion}]{Conclusion}\par
The Physicochemical standards for scientific evaluation of Majoon Aarad Khurma and granules of Majoon Aarad Khurma were estimated and the standards were evaluated as recommended by CCRUM.\par
Based on the finding it is concluded that ? Granules possessed the same principles and maintained same characteristics as traditional dosage form Majoon Aarad Khurma. ? The granules of Majoon Aarad Khurma were found to be more stable, convenient and comfortable in usage and dispensing, and also safe, light, efficacious, cost effective and quality controlled. ? Stevia a natural sweetening agent which was used as base for granules was evaluated for its toxicity in animal models and no toxicity was found, hence Stevia can be used as safe and efficacious sweetening agent in preparation of granules as well as in other Unani formulations.\begin{figure}[htbp]
\noindent\textbf{1}\includegraphics[]{image-2.png}
\caption{\label{fig_1}Fig. 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.03659491193737769\textwidth}P{0.23786692759295497\textwidth}P{0.3459882583170254\textwidth}P{0.12641878669275927\textwidth}P{0.10313111545988257\textwidth}}
Sl. No.\tabcellsep UNANI NAME\tabcellsep BOTANICAL NAME\tabcellsep PART USED\tabcellsep QUANTITY\\
1\tabcellsep Khurma\tabcellsep Phoenix dactylifera\tabcellsep Fruit\tabcellsep 200gm\\
2\tabcellsep Samagh arbi\tabcellsep Acacia arabica\tabcellsep Gum\tabcellsep 200gm\\
3\tabcellsep Singhara khushk\tabcellsep Trapa bispinosa\tabcellsep Fruit\tabcellsep 200gm\\
4\tabcellsep Satawar\tabcellsep Asparagus rasemosus\tabcellsep Root\tabcellsep 50gm\\
5\tabcellsep Jaiphal\tabcellsep Myristica fragrans\tabcellsep Nutmeg\tabcellsep 1.25gm\\
6\tabcellsep Javitri\tabcellsep Myristica fragrans\tabcellsep Mace\tabcellsep 1.25gm\\
7\tabcellsep Qaranfal\tabcellsep Myrtus caryophyllus\tabcellsep Flower Buds\tabcellsep 2.5gm\\
8\tabcellsep Maghaze Badam\tabcellsep Prunus amygdalus\tabcellsep Fruit\tabcellsep 25gm\\
9\tabcellsep Maghaze Chilghoza\tabcellsep Pinus gerardiana\tabcellsep Fruit\tabcellsep 25gm\\
10\tabcellsep Maghaze Fundaq\tabcellsep Corylus avellana\tabcellsep Fruit\tabcellsep 25gm\\
11\tabcellsep Maghaze Pambadana\tabcellsep Gossypium herbaceum\tabcellsep Fruit\tabcellsep 5gm\\
12\tabcellsep Qand safaid\tabcellsep Sugar\tabcellsep Sugarcane\tabcellsep 1kg\end{longtable} \par
 
\caption{\label{tab_0}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2} \par 
\begin{longtable}{P{0.03561904761904762\textwidth}P{0.24447619047619046\textwidth}P{0.35619047619047617\textwidth}P{0.10847619047619049\textwidth}P{0.10523809523809524\textwidth}}
Sl. No.\tabcellsep UNANI NAME\tabcellsep BOTANICAL NAME\tabcellsep PART USED\tabcellsep QUANTITY\\
1\tabcellsep Khurma\tabcellsep Phoenix dactylifera\tabcellsep Fruit\tabcellsep 200gm\\
2\tabcellsep Kamagh arbi\tabcellsep Acacia arabica\tabcellsep Gum\tabcellsep 200gm\\
3\tabcellsep Singhara khushk\tabcellsep Trapa bispinosa\tabcellsep Fruit\tabcellsep 200gm\\
4\tabcellsep Satawar\tabcellsep Asparagus rasemosus\tabcellsep Root\tabcellsep 50gm\\
5\tabcellsep Jaiphal\tabcellsep Myristica fragrans\tabcellsep Nutmeg\tabcellsep 1.25gm\\
6\tabcellsep Javitri\tabcellsep Myristica fragrans\tabcellsep Mace\tabcellsep 1.25gm\\
7\tabcellsep Qaranfal\tabcellsep Myrtus caryophyllus\tabcellsep Fruit\tabcellsep 2.5gm\\
8\tabcellsep Maghaze Badam\tabcellsep Prunus amygdalus\tabcellsep Fruit\tabcellsep 25gm\\
9\tabcellsep Maghaze Chilghoza\tabcellsep Pinus gerardiana\tabcellsep Fruit\tabcellsep 25gm\\
10\tabcellsep Maghaze Fundaq\tabcellsep Corylus avellana\tabcellsep Fruit\tabcellsep 25gm\\
11\tabcellsep Maghaze Pambadana\tabcellsep Gossypium herbaceum\tabcellsep Fruit\tabcellsep 5gm\\
12\tabcellsep Stevia plant powder\tabcellsep Stevia rebaudeana\tabcellsep leaves\tabcellsep 3.50gm\end{longtable} \par
 
\caption{\label{tab_1}Table 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3} \par 
\begin{longtable}{P{0.036170212765957444\textwidth}P{0.4727963525835866\textwidth}P{0.17051671732522797\textwidth}P{0.17051671732522797\textwidth}}
Sl. No\tabcellsep Physico Chemical Properties\tabcellsep MAK\tabcellsep GMAK\\
\tabcellsep Organoleptic Properties\tabcellsep \tabcellsep \\
\tabcellsep Apearance\tabcellsep Semi Solid\tabcellsep Granules\\
1.\tabcellsep Odour\tabcellsep Brownish\tabcellsep Brownish\\
\tabcellsep Smell\tabcellsep Pleasant\tabcellsep Pleasant\\
\tabcellsep Taste\tabcellsep Sweet\tabcellsep Sweet\\
2.\tabcellsep Alcohol Soluble Matter\tabcellsep 65.5\%\tabcellsep 24.6\%\\
3.\tabcellsep Water Soluble Matter\tabcellsep 46.5\%\tabcellsep 36.6\%\\
\tabcellsep Successive Extractives\tabcellsep \tabcellsep \\
\tabcellsep Petroleum Ether\tabcellsep 2.4\%\tabcellsep 4.2\%\\
4.\tabcellsep Chloroform\tabcellsep 0.4\%\tabcellsep 0.6\%\\
\tabcellsep Ethyl Alcohol\tabcellsep 41.7\%\tabcellsep 19.13\%\\
\tabcellsep Aqueous\tabcellsep 35\%\tabcellsep 37.2\end{longtable} \par
 
\caption{\label{tab_2}Table 3 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{4} \par 
\begin{longtable}{P{0.09296875\textwidth}P{0.4017578125\textwidth}P{0.046484375\textwidth}P{0.1361328125\textwidth}P{0.17265624999999998\textwidth}}
Extract\tabcellsep Solvent System\tabcellsep No. of Spots\tabcellsep R f Value\tabcellsep Colours\\
\tabcellsep Toluene: Ethyl\tabcellsep \tabcellsep 0.27\tabcellsep Green\\
MAK\tabcellsep acetate (7:3, with 2\tabcellsep 3\tabcellsep 0.31\tabcellsep Yellow\\
Ethanol\tabcellsep drop Sulphuric acid)\tabcellsep \tabcellsep 0.50\tabcellsep Pink\\
\tabcellsep \tabcellsep \tabcellsep 0.31\tabcellsep Green\\
\tabcellsep Toluene: Ethyl\tabcellsep \tabcellsep 0.36\tabcellsep Brown\\
GMAK\tabcellsep acetate(7:3, with 2\tabcellsep 5\tabcellsep 0.50\tabcellsep Light Pink\\
Ethanol\tabcellsep drop Sulphuric acid)\tabcellsep \tabcellsep 0.68\tabcellsep Pink\\
\tabcellsep \tabcellsep \tabcellsep 0.75\tabcellsep Yellow\end{longtable} \par
 
\caption{\label{tab_3}Table 4 :}\end{figure}
 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Moben et al. ()]{b3}\label{b3} 	 		\textit{},  		 			Fam Moben 		,  		 			Qanoone 		,  		 			Delhi 		.  		1934. Jamia Barqi Press. p. pnm.  	 
\bibitem[Harborne ()]{b12}\label{b12} 	 		\textit{},  		 			J B Harborne 		.  	 	 		\textit{Phytochemical methods}  		1973. Chapman and Hall. p. .  	 	 (Ltd) 
\bibitem[Kabiruddin and Al-Akseer ()]{b23}\label{b23} 	 		\textit{},  		 			H M Kabiruddin 		,  		 			Al-Akseer 		.  		2003. New Delhi: Ajaz publication House. 2 p. .  	 
\bibitem[Khan (ed.) ()]{b2}\label{b2} 	 		\textit{A scientific study of some Unani drugs used for improving the male sexual function. Aligarh-Thesis submitted to Dept},  		 			M N Khan 		.  		Ilmul Advia, A.K.T.C, A.M.U (ed.)  		1993.  	 
\bibitem[Acute and sub-chronic oral toxicity studies of an aqueous stem bark extract of Pterocarpus soyauxii Taub (Papilionaceae) in rodents Journal of Ethnopharmacology ()]{b6}\label{b6} 	 		‘Acute and sub-chronic oral toxicity studies of an aqueous stem bark extract of Pterocarpus soyauxii Taub (Papilionaceae) in rodents’.  	 	 		\textit{Journal of Ethnopharmacology}  		2011. 133 p. .  	 
\bibitem[Mccary and Carry ()]{b0}\label{b0} 	 		\textit{Aphrodisiac and Anaphrodisiacs in Mccary's Human Sexuality. 4 th ed},  		 			J L Mccary 		,  		 			Mc Carry 		,  		 			SP 		.  		1974. p. .  	 
\bibitem[Basheer et al.]{b1}\label{b1} 	 		 			A Basheer 		,  		 			Risalae Quwwate Bah 		,  		 			Kanpur 		.  		\textit{Munshi Naval Kishore; 1886. pnm},  				 	 
\bibitem[Siddique ()]{b15}\label{b15} 	 		‘Chemical composition of essential oil by different extraction methods and fatty acid analysis of the leaves of Stevia Rebaudiana Bertoni’.  		 			A B Siddique 		.  		 \xref{http://dx.doi.org/10.1016/j.arabjc.2012.01.004}{10.1016/j.arabjc.2012.01.004}.  	 	 		\textit{Arabian Journal of Chemistry}  		2012.  	 
\bibitem[Luo ()]{b16}\label{b16} 	 		‘Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine. A systematic review of randomized clinical trials’.  		 			H Luo 		.  		 doi: 10.101 6/j.jep.2012.01.031.  	 	 		\textit{J. Ethnopharmacol}  		2012.  	 
\bibitem[Vogel ()]{b13}\label{b13} 	 		\textit{Elementary practice organic chemistry, qualitative organic analysis},  		 			Vogel 		.  		1970. 3 p. 743.  	 	 (Great Britain: Longman Group Limited) 
\bibitem[Mohammad ()]{b5}\label{b5} 	 		‘Evaluation of lithotriptic activity of Tukhme Karafs (seeds of Apium graveolens Linn) in experimental animals’.  		 			T H Mohammad 		.  	 	 		\textit{Dept. of Ilmul Advia}  		2010.  	 	 (NIUM) 
\bibitem[Aulton and Wells ()]{b9}\label{b9} 	 		‘Evaluation of tapioca sago starch as a binder in tablet formulation’.  		 			M E Aulton 		,  		 			T I Wells 		.  	 	 		\textit{IJPI's Journal of Pharmacognosy and Herbal Formulations}  		1988. 2010. 1  (1) .  		 			Churchill Livingstone London, England 		 	 	 (Pharmaceutics: The Science of Dosage Form Design) 
\bibitem[Hertzel]{b14}\label{b14} 	 		\textit{Evidence-Based Diabetes Care},  		 			C Hertzel 		,  		 			Gerstein 		.  		 	 
\bibitem[Fan ()]{b17}\label{b17} 	 		‘Future development of global regulations of Chinese herbal products’.  		 			T P Fan 		.  		 \xref{http://dx.doi.org/10.1016/j.jep.2012.02.029}{10.1016/j.jep.2012.02.029}.  	 	 		\textit{J. Ethnopharmacol}  		2012.  	 
\bibitem[Said]{b4}\label{b4} 	 		‘Hamdard Pharmacopoeia of Eastern Medicine’.  		 			H M Said 		.  	 	 		\textit{New Delhi: Sri Sat Guru Publications}  		1997 p. 353.  	 
\bibitem[Rance et al. ()]{b26}\label{b26} 	 		‘How much of a priority is treating erectile dysfunction: a study of patients' perceptions’.  		 			J Rance 		,  		 			C Phillips 		,  		 			S Davies 		.  	 	 		\textit{Diabetic Med}  		2003. 20 p. .  	 
\bibitem[Siddique et al. ()]{b24}\label{b24} 	 		‘Impotence: Unani concepts and its management’.  		 			Msh Siddique 		,  		 			S M Ashraf 		,  		 			Mmh Siddiqui 		.  	 	 		\textit{The Journal of Research and Education in Indian Medicine}  		1992. p. .  	 
\bibitem[Kinsey ()]{b22}\label{b22} 	 		‘Masters and Johnson on Sex and human loving’.  		 			Kinsey 		.  	 	 		\textit{Jaico publishing house},  				 (Mumbai)  		1948. 2002. p. 572.  	 
\bibitem[Jenkins et al. ()]{b19}\label{b19} 	 		\textit{Quantitative Pharmaceutical Chemistry. 6 th ed},  		 			G L Jenkins 		,  		 			A M Knevel 		,  		 			F E Digangi 		.  		2008. New Delhi: CBS Publishers. p. 379.  	 
\bibitem[Sutharsingh et al. (2011)]{b11}\label{b11} 	 		‘Quantitave phytochemical estimation and antioxidant studies on aerial parts of Naravelia zeylanica dc’.  		 			R Sutharsingh 		,  		 			S Kavimani 		,  		 			B Jayakar 		,  		 			M Uvarani 		,  		 			A Thangathirupathi 		.  	 	 		\textit{International Journal of Pharmaceutical Studies and Research}  		2011 April June. p. .  	 	 (II (II) 
\bibitem[Sahoo ()]{b18}\label{b18} 	 		 			Niharika Sahoo 		.  	 	 		\textit{Herbal drugs: Standards and regulation. Department of Biotechnology},  				 (West Bengal, India)  		2010. 81 p. .  	 
\bibitem[Shamsi ()]{b21}\label{b21} 	 		‘Standardization and Pharmacological Evaluation of two Nervine Unani Formulations’.  		 			Shamsi 		.  	 	 		\textit{Thesis. Aligarh: Dept. of Ilmul Advia}  		2008. AMU. p. 85.  	 
\bibitem[Afaq and Siddiqui]{b10}\label{b10} 	 		\textit{Standardization of herbal drugs},  		 			S H Afaq 		,  		 			Tajuddin Siddiqui 		,  		 			Mmh 		.  		Aligarh: Aligarh: Publication AMU. p. 100.  	 
\bibitem[Irshad ()]{b7}\label{b7} 	 		‘Temperature standardization and comparative toxicity study of Kushta Sammul Far prepared by different methods’.  		 			S Irshad 		.  	 	 		\textit{Thesis. Dept. of Ilmul Advia}  		2009.  	 	 (NIUM) 
\bibitem[Singh ()]{b25}\label{b25} 	 		‘The Effect of Testosterone on the Cavernous Tissue and Erectile function’.  		 			Sahib Singh 		,  		 			R 		.  	 	 		\textit{World J. Ural}  		1997. 15 p. 21.  	 
\bibitem[Goodman ()]{b20}\label{b20} 	 		‘The Pharmacological Basis of’.  		 			Gilman's Goodman 		.  	 	 		\textit{Medical publishing Division}  		Therapeutics. 10 th ed. U.S.A: Mc Graw-Hill (ed.)  		2001. p. 1687.  	 
\bibitem[Ibn Baitar. Aljame al Mufradat al Advia wa al Aghzia (ed.) ()]{b8}\label{b8} 	 		\textit{Urdu translation by CCRUM New Delhi: Dept of AYUSH, Ministry of H \& FW. Govt. of India},  		Ibn Baitar. Aljame al Mufradat al Advia wa al Aghzia (ed.)  		1999. 1 p. 437.  	 
\end{bibitemlist}
 			 		 	 
\end{document}
